Location History:
- Lexington, KY (US) (2019 - 2021)
- Muncie, IN (US) (2022)
Company Filing History:
2 out of 882 
1 out of 1,507 
1 out of 8 Years Active: 2019-2022
Title: Emil Khisamutdinov: Innovator in RNA Nanostructures
Introduction
Emil Khisamutdinov, based in Lexington, KY, is a prominent inventor renowned for his significant contributions to the field of RNA nanotechnology. With a total of three patents to his name, Khisamutdinov's innovative work focuses on the development of self-assembled RNA cage nanoparticles and advanced RNA-based compositions aimed at therapeutic applications.
Latest Patents
Emil's latest patents illustrate his groundbreaking research. One of his key inventions is the "Self-assembled 3D RNA cage nanoparticles." This patent discloses three-dimensional cage molecules composed of RNA, along with a composition including these cage molecules and methods for administering them to subjects. Another notable invention is the "RNA-based compositions and adjuvants for prophylactic and therapeutic treatment." This patent details an artificial RNA nanostructure that is designed to induce immune responses, comprising multiple external and internal RNA strands organized into various nanostructures, complete with pRNA three-way junction motifs.
Career Highlights
Throughout his career, Emil Khisamutdinov has worked with reputable institutions such as the University of Kentucky Research Foundation and the Ohio State Innovation Foundation. His association with these organizations underscores his dedication to advancing research in innovative biotechnology.
Collaborations
Emil has collaborated with respected colleagues in the field, including Peixuan Guo and Daniel Jasinski. These collaborations have contributed to the rich exchange of ideas and insights, enhancing the development of his inventive works.
Conclusion
Emil Khisamutdinov's impressive body of work exemplifies his commitment to innovation in RNA technology. His patents not only reflect his ingenuity but also hold promise for significant advancements in therapeutic treatments. As the field of biotechnology continues to evolve, Khisamutdinov remains at the forefront, pushing the boundaries of what's possible with RNA-based inventions.